OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis
Aya A. Elkhodiry, H.M. El Tayebi
Non-coding RNA Research (2021) Vol. 6, Iss. 4, pp. 187-199
Open Access | Times Cited: 10

Showing 10 citing articles:

Glucose metabolism is controlled by non-coding RNAs in autoimmune diseases; a glimpse into immune system dysregulation
Raed Obaid Saleh, Raed Fanoukh Aboqader Al-Aouadi, Nujud Almuzaini, et al.
Human Immunology (2025) Vol. 86, Iss. 3, pp. 111269-111269
Closed Access | Times Cited: 1

Neuroprotective and antioxidant effects of docosahexaenoic acid (DHA) in an experimental model of multiple sclerosis
Ana Muñoz-Jurado, Begoña M. Escribano, Alberto Galván, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 124, pp. 109497-109497
Closed Access | Times Cited: 7

Animal model of multiple sclerosis: Experimental autoimmune encephalomyelitis
Ana Muñoz-Jurado, Begoña M. Escribano, Isaac Túnez
Methods in cell biology (2024), pp. 35-60
Closed Access | Times Cited: 1

Rs205764 and rs547311 in linc00513 may influence treatment responses in multiple sclerosis patients: A pharmacogenomics Egyptian study
Nada Sherif Amin, Mostafa K. Abd El‐Aziz, Mohamed Hamed, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2

Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma
Monaza Adeeb, Lubna Therachiyil, Safwan Moton, et al.
International review of cell and molecular biology (2023), pp. 149-171
Closed Access | Times Cited: 2

The next frontier in multiple sclerosis therapies: Current advances and evolving targets.
K. Trideva Sastri, Neha Gupta, Anbarasu Kannan, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177080-177080
Closed Access

Ataxin‐1 controls the expression of specific noncoding RNAs in B cells upon autoimmune demyelination
Qin Ma, Alessandro Didonna
Immunology and Cell Biology (2023) Vol. 101, Iss. 4, pp. 358-367
Open Access | Times Cited: 1

Insight into Early Diagnosis of Multiple Sclerosis by Targeting Prognostic Biomarkers
Nidhi Puranik, Dhananjay Yadav, Minseok Song
Current Pharmaceutical Design (2023) Vol. 29, Iss. 32, pp. 2534-2544
Closed Access | Times Cited: 1

The Function of MicroRNAs in Autoimmune Diseases
Patricia Mendes Demo
Science Insights (2022) Vol. 40, Iss. 5, pp. 499-505
Open Access

Page 1

Scroll to top